Coenzyme Q10 terclatrate and creatine in chronic heart failure: A randomized, placebo-controlled, double-blind study

Clinical Cardiology

Volumn 34, Issue 4, 2011, Pages 211-217

  Fumagalli, Stefano ^a   Fattirolli, Francesco ^a   Guarducci, Lorenzo ^a   Cellai, Tommaso ^a   Baldasseroni, Samuele ^a   Tarantini, Francesca ^a   Di Bari, Mauro ^a   Masotti, Giulio ^b   Marchionni, Niccolò ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Eughenos Anti Aging Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EUFORTYN; FUROSEMIDE; OXYGEN; PLACEBO; Q TER; UBIDECARENONE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; UBIQUINONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SICKNESS IMPACT PROFILE; TREATMENT DURATION; WORK CAPACITY; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; NUTRITIONAL DEFICIENCY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLACEBO EFFECT; PSYCHOLOGICAL ASPECT; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CREATINE; DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MEDICATION ADHERENCE; OXYGEN CONSUMPTION; PLACEBO EFFECT; QUALITY OF LIFE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UBIQUINONE; VENTRICULAR FUNCTION, LEFT;

EID: 79953698833     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20846     Document Type: Article

References (33)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:1825-1852.
2. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072. (Pubitemid 35440290)
3. Butler J, Kalogeropoulos A, Georgiopoulou V, et al. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail. 2008;1:125-133.
4. Marchionni N, Di Bari M, Fumagalli S, et al. Variable effect of comorbidity on the association of chronic cardiac failure with disability in community-dwelling older persons. Arch Gerontol Geriatr. 1996;23:283-292. (Pubitemid 27033923)
5. Masoudi FA, Rumsfeld JS, Havranek EP, et al. Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004;10:368-373. (Pubitemid 41080215)
6. Rodríguez-Artalejo F,Guallar-Castillón P, Pascual CR, et al.Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med. 2005;165:1274-1279. (Pubitemid 40989592)
7. Heo S, Moser DK, Lennie TA, et al. A comparison of health-related quality of life between older adults with heart failure and healthy older adults. Heart Lung. 2007;36:16-24. (Pubitemid 46096594)
8. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol. 2001;37:1765-1774. (Pubitemid 32499957)
9. Vescovo G, Ravara B, Gobbo V, et al. L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol. 2002;283:C802-C810. (Pubitemid 34920313)
10. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. Nutr Rev. 2007;65(6 part 1):286-293. (Pubitemid 351804363)
11. Langsjoen PH, Langsjoen AM. Overview of the use of CoQ10 in cardiovascular disease. Biofactors. 1999;9:273-284. (Pubitemid 29289007)
12. Pepe S,Marasco SF, Haas SJ, et al. Coenzyme Q10 in cardiovascular disease. Mitochondrion. 2007;7(suppl):S154-S167.
13. Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev. 2001;53:161-176. (Pubitemid 32476115)
14. Fetoni AR, Piacentini R, Fiorita A, et al. Water-soluble Coenzyme Q(10) formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res. 2009;1257:108-116.
15. Soukoulis V, Dihu JB, Sole M, et al. Micronutrient deficiencies: an unmet need in heart failure. J Am Coll Cardiol. 2009;54:1660-1673.
16. Carli F, Corvi Mora P, Canal T. Co-grinding process for the preparation of a ternary composition. European Patent Office. http://v3.espacenet.com/ publicationDetails/biblio?CC=WO&NR=03097012A1&KC=A1&FT=D&date= 20031127&DB=EPODOC&locale=en-EP#. 2003.
17. Corvi Mora P, Canal T, Ruzzier F, et al. Composition containing micronutrients with improved anti-oxidant activity and the use thereof. http://www.faqs.org/patents/app/20080219963#ixzz10OdTG2CD. 2008.
18. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106:1883-1892.
19. Marchionni N, Ferrucci L, Baldasseroni S, et al. Item re-scaling of an Italian version of the sickness impact profile: effect of age and profession of the observers. J Clin Epidemiol. 1997;50:195-201. (Pubitemid 27129719)
20. De Groote P, Isnard R, Assyag P, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail. 2007;9:1205-1211. (Pubitemid 350153640)
21. Tarnopolsky MA. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev. 2008;60:1561-1567.
22. Witte KK, Clark AL. Micronutrients and their supplementation in chronic cardiac failure: an update beyond theoretical perspectives. Heart Fail Rev. 2006;11:65-74. (Pubitemid 43986209)
23. Molyneux SL, Florkowski CM, George PM, et al. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol. 2008;52:1435-1441.
24. Khatta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med. 2000;132:636-640. (Pubitemid 30217556)
25. Belardinelli R, Muçaj A, Lacalaprice F, et al. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors. 2005;25:137-145. (Pubitemid 44070841)
26. Belardinelli R, Muçaj A, Lacalaprice F et al. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J. 2006;27:2675-2681. (Pubitemid 44729868)
27. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med. 1997;18(suppl):S159-S168.
28. Sander S, Coleman CI, Patel AA, et al. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. 2006;12:464-472. (Pubitemid 46106977)
29. Mortensen SA. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio" - a multinational trial. Biofactors. 2003;18:79-89.
30. Allard ML, Jeejeebhoy KN, Sole MJ. The management of conditioned nutritional requirements in heart failure. Heart Fail Rev. 2006;11:75-82. (Pubitemid 43994886)
31. Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res. 1995;30:413-418.
32. Witte KK, Nikitin NP, Parker AC, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005;26:2238-2244. (Pubitemid 41541386)
33. Xu J, Seo AY, Vorobyeva DA, et al. Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats. PLoS One. 2010;5:e10572.